HomeINDV • NASDAQ
add
Indivior PLC
Previous close
$23.88
Day range
$23.06 - $23.75
Year range
$7.33 - $25.10
Market cap
2.90B USD
Avg Volume
3.29M
P/E ratio
29.05
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 302.00M | 1.00% |
Operating expense | 179.00M | 0.56% |
Net income | 18.00M | 118.56% |
Net profit margin | 5.96 | 118.37% |
Earnings per share | 0.51 | 15.91% |
EBITDA | 71.00M | 61.36% |
Effective tax rate | 70.97% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 510.00M | 34.56% |
Total assets | 1.45B | -5.41% |
Total liabilities | 1.71B | 3.20% |
Total equity | -257.00M | — |
Shares outstanding | 124.77M | — |
Price to book | -11.59 | — |
Return on assets | 12.56% | — |
Return on capital | 182.99% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 18.00M | 118.56% |
Cash from operations | 158.00M | 79.55% |
Cash from investing | -17.00M | -1,800.00% |
Cash from financing | -5.00M | 85.71% |
Net change in cash | 138.00M | 155.56% |
Free cash flow | 142.00M | -7.57% |
About
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
Founded
Sep 26, 2014
Website
Employees
1,000
